baber/WOPTO huggingface dataset:
Patent NZ-267410-A (NZ)
Title: 5-[(nitrogen containing heteroaryl)-alkyl-(fused aryl or heteroaryl)]methyl-2,4-dioxothiazolidine derivatives; pharmaceutical compositions
Inventor: FREUND PETER
IPC: A61K31/42
Filed: 1994-05-19
Abstract: PCT No. PCT/EP94/01619 Sec. 371 Date Nov. 21, 1995 Sec. 102(e) Date Nov. 21, 1995 PCT Filed May 19, 1994 PCT Pub. No. WO94/27995 PCT Pub. Date Dec. 8, 1994Compounds of formula I    <IMAGE>  (I)  in which A denotes a carbocyclic ring with 5 or 6 carbon atoms or a heterocyclic ring with a maximum of 4 heteroatoms in which the heteroatoms can be the same or different and denote oxygen, nitrogen or sulphur and the heterocycles can if desired carry an oxygen atom on one or several nitrogen atoms, B denotes -CH=CH-, -N=CH-, -CH=N-, O or S, W denotes CH2, O, CH(OH), CO or -CH=CH-, X denotes S, O or NR2 in which the residue R2 is hydrogen or C1-C6 alkyl, Y is CH or N, R denotes naphthyl, pyridyl, furyl, thienyl or phenyl which if desired is mono- or disubstituted with C1-C3 alkyl, CF3, C1-C3 alkoxy, F, Cl or bromine, R1 denotes hydrogen or C1-C6 alkyl and n equals 1-3 as well as their tautomers, enantiomers, diastereomers and physiologically tolerated salts, processes for their production as well as pharmaceutical agents that contain these compounds for the treatment of diabetes.
Patent NZ-274948-A (NZ)
Title: Injection cartridge; dual chamber type with angled grooved bypass connection the chambers
Inventor: HJERTMAN BIRGER
IPC: A61M5/178
Filed: 1994-10-10
Abstract: An injection cartridge (1) of the dual-chamber type has a bypass connection (12) between its two chambers (9, 10) which is arranged such that the interior wall of the cartridge is modified in a predetermined area in such a way that the movable wall (11) between the two chambers does not seal completely against the interior wall in said area. According to the invention, the modification of said wall is arranged as a plurality of lands and grooves (12) which have a direction that is inclined in relation to the longitudinal axis of the cartridge barrel. <IMAGE>
Patent NZ-334277-A (NZ)
Title: 7'alpha'('xi'-aminoalkyl)estratrienes
Inventor: BOHLMANN ROLF
IPC: C07J53/00
Filed: 1997-08-20
Abstract: 7 alpha -(xi-Aminoalkyl)-oestratriene derivatives of formula (I) and their acid-addition salts wherein: SK = -(CH2)m-NA-CHB-CHD-(CH2)n-SOx-(CH2)3-E; A = H or 1-5C alkyl and B, D = H; or A+B = (CH2)p and D = H; or A+D = (CH2)q and B = H; E = optionally mono- to perfluorinated ethyl; R3 = H, 1-8C hydrocarbyl or COR3'; R3' = H, 1-8C hydrocarbyl or phenyl;  R11 = H, halogen or ONO2;  R14, R15a, R15b, R16a and R16b = H, or R14+R15a = a bond or a CH2 bridge, or R15b = Me and R15a = H, or R15a and R15b = Me, or R15b+R16b = a CH2 bridge, or R16a or R16b = halogen, or R16a+R16b = methylidene; and the remaining substituents from R14, R15a, R15b, R16a and R16b = H; R17' = H, alkyl, 2-5C alkenyl, 2-5C alkynyl or CF3, or R17'+R14 = CH2CH2 when R17' is in the alpha position; R17" = H or COR17"'; R17"' = H or hydrocarbyl; m = 4-6, n, x = 0-2, p = 2-5, q = 2-4; provided that, if A+B do not form (CH2)p or A+D do not form (CH2)q then R11, R14, R15a, R15a, R16a and R16b are not all H.
Patent NZ-334737-A (NZ)
Title: Brake pad to contact rotating disc and having grooves each with widened mouth typically for wet disc application
Inventor: PARSONS FRANCIS EDWARD
IPC: F16D65/092
Filed: 1995-08-24
Abstract: Grooves 17 are angled rearwardly from a radial line from inlet ends 19.  Ends 19 each have widened mouth portion 20 and a zone of decreasing groove width.
Patent NZ-336605-A (NZ)
Title: Monitoring of remote file access on a public computer network such as the internet
Inventor: LEVY JEFFREY C
IPC: G06F21/31
Filed: 1998-01-09
Abstract: Provided is a method of monitoring remote file access on a computer network (4), more particularly measuring visits to a web site and collecting personal characteristics of the visitors, by rerouting a resource access request message, generated on a client system (1), through a logging module (13), collecting information about the message, and transmitting the message to a remote data resources server (2).
Patent NZ-337639-A (NZ)
Title: Hybrid dendroaspin based polypeptide comprising RGD motif and further amino acid sequence, preparation, pharmaceutical composition comprising it
Inventor: LU XINJIE
IPC: C07K14/815
Filed: 1998-03-20
Abstract: Dendroaspin, a polypeptide neurotoxin analogue is modified by recombinant DNA techniques, particularly "loop grafting" to provide a modified polypeptide.  The modified polypeptide is constructed so as to retain dendroaspin activity e.g. platelet adhesion to fibrinogen in addition to possessing one or more further biological or biochemical activities not native to dendroaspin, e.g. platelet derived growth factor (PDGF) activity or hirudin activity. A hybrid dendroaspin-based polypeptide is described that comprises a first amino acid sequence including the RGD motif and conferring platelet-binding activity and a further amino acid sequence conferring activity other than platelet-binding activity or glutathione S-transferase activity.
Patent NZ-500156-A (NZ)
Title: Toothbrush with head being oval shaped and having central ridge on a face from which bristles project outwardly therefrom
Inventor: SMITH-HOLLEY ALLAN WAYNE
IPC: A46B5/00
Filed: 1999-10-11
Abstract: The toothbrush has an oval shaped head and a ridge formed on the head from which bristles project outwardly.  Preferably the bristles are soft or medium and are trimmed so as to lie on a convex curved surface.
Patent NZ-502166-A (NZ)
Title: The subscriber identity control further includes on activation a message to both the SIM unit and server as to whether access is allowed
Inventor: VATANEN HARRI
IPC: G06Q20/34
Filed: 1998-06-16
Abstract: A procedure for the control of applications stored in a subscriber identity module in a data communication system comprising a data communication network (4), a terminal device (MS) connected to the data communication network, a subscriber identity module (SIM) connected to the terminal device and containing a stored application that makes use of the data communication network and is used by means of the terminal device, and an application control server (1) connected to the data communication network. A key list comprising one or more application-specific keys is stored in the subscriber identity module (SIM) characterised in that the procedure includes the activation and/or closing message including an application specific key generated in the application control server; a message being sent to the SIM; and a key checked in the SIM and if the key is identified to be correct then the application is either activated or closed according to the message.
Patent NZ-502543-A (NZ)
Title: A teat cup having a flexible portion in its length
Inventor: VAN DEN BERG KAREL
IPC: A01J5/08
Filed: 1999-05-06
Abstract: A teat cup (2) for milking a teat of an animal to be milked has at least a portion of its length flexible and/or deformable (9) in such a manner that one end of the teat cup may be bent to a non-vertical position such as in the direction of the other end of the teat.  The deformable/flexible portion of the teat can be a vulcanized spring (12). A milking robot having a robot arm with at least one teat cup as defined above is also disclosed.
Patent NZ-504671-A (NZ)
Title: A stable pharmaceutical composition comprising a water soluble disodium salt of 5-isopropyl-pyridine-2-sulphonic acid 6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(2-1H-tetrazol-5-yl-pyridin-4-yl)-pyrimidin-4-ylamide
Inventor: LOELIGER PETER
IPC: A61K47/18
Filed: 2000-05-19
Abstract: A stable pharmaceutical composition comprises a water soluble disodium salt of 5-isopropyl-pyridine-2-sulphonic acid   6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(2-1H-tetrazol-5-yl-pyridin-4-yl)-pyrimidin-4-ylamide, optionally a metal complex forming agent and a buffer having a pH above 8.2 but not higher than 10.  The buffer is preferably 2-amino-2-hydroxymethyl-1,3-propanediol and the complex forming agent is preferably ethylene diaminetetraacetic acid disodium salt.
Patent NZ-505262-A (NZ)
Title: Boat winch and winch and anchor chain features
Inventor: CHAMBERS CHRISTOPHER PAUL
IPC: B63B23/48
Filed: 2000-06-16
Abstract: A rope and chain winch includes top and bottom chain wheel discs 11, 10 mounted on a spindle1, a clutch with lower and upper cones 5, 20 engaged on the flat 6 of the spindle and movable to selectively engage or disengage the chain wheel discs with the spindle, and a clutch nut 27 having a central aperture and being movable rotationally and longitudinally on the spindle on mutually engaging threads on the spindle and the central aperture.  A split-collet stop 30 on the spindle prevents the longitudinal movement of the clutch nut away from the chain wheel beyond a predetermined position. A carrier 36 is mounted for rotation on the spindle and includes a pinion engagable by a handle, the pinion teeth engaging the inner teeth 28 of the clutch nut. The pawls 23 in the walls of the carrier engage the teeth 22 on the upper clutch cone so that rotation of the carrier in one direction will rotate the upper clutch cone and spindle to provide a manual override if the spindle motor should fail. Rotation of the handle in one direction rotates the clutch nut so that the nut moves toward the chain wheel to ensure that the clutch cones engage the chain discs to cause the chain discs to be rotated by the motor driven spindle.  Rotation of the handle in the other direction rotates the clutch nut in the opposite direction so that the clutch nut moves away from the chain wheel to engage the stop and release the chain discs from engagement with the spindle.  However, the engagement of the clutch nut with the stop causes the carrier to rotate whereby the dog lever 35 in the wall of the carrier engages the lug 15 on the chain wheel disc 11 to rotate the chain wheel without rotation of the spindle.
Patent NZ-508189-A (NZ)
Title: Roller panel for use in partitions with a varying range of heights with connectors
IPC: A47B45/00
Filed: 2000-11-15
Abstract: A partition panel adapted to stand upright from a floor surface includes a base frame part (3), two side frame parts (1, 2) and an infill section (4) which is fixed at or near the base part.  One end (7) of the infill section (4) is extendible and retractable between the side parts (1,2) in a vertical direction enabling the height of the infill section (4) to be varied.  Such a panel may be part of a shelf assembly, the assembly including a further frame having a bottom frame part and two side frame parts.  The further frame being maintained in spaced apart relationship from the panel by cross members.   At least one shelf 28 extends between the panel and the further frame.
Patent NZ-509612-A (NZ)
Title: Modulating multiple lineage kinase proteins and screening compounds which modulate multiple lineage kinase proteins
Inventor: MARONEY ANNA
IPC: C12Q1/68
Filed: 1999-08-18
Abstract: Methods for identifying compounds which modulate activity of a multiple lineage kinase protein and promotes cell survival or cell death comprising the steps of contacting the cell containing the multiple lineage kinase protein with the compound, determining whether the compound decreases activity of the multiple lineage kinase protein, and determining whether the compound promotes cell survival are disclosed. Also disclosed are methods for identifying compounds which may be useful in the treatment of neurodegenerative disorders and/or inflammation, methods for modulating the activity of a multiple lineage kinase protein comprising contacting the protein or a cell containing the protein with an indeno- or indolo- compound of the invention and methods of treating neurodegenerative disorders and/or inflammation.
Patent NZ-510977-A (NZ)
Title: Novel G protein-coupled receptor proteins, DNAs thereof and ligands to the same
Inventor: OHTAKI TETSUYA
IPC: A61K48/00
Filed: 1999-10-26
Abstract: Rat cerebellum-derived and human brain-derived G protein coupled receptor proteins or salts thereof, their partial peptides, amides, esters or salts thereof, ligands to the same, a method/kit for screening compounds that alter the binding property between the ligands and the G protein coupled receptor proteins, compounds obtained by the screening or salts thereof, and antibodies to the G protein coupled receptor proteins.  The rat cerebellum-derived and human brain-derived G protein coupled receptor proteins and the like are useful: (1) for determination of a ligand to the receptor protein, (2) as an agent for the prevention and/or treatment of diseases associated with dysfunction of the G protein coupled receptor, (3) as a genetic diagnostic agent, (4) for quantification of a ligand to the G protein coupled receptor, (5) for screening of a compound that alters the binding property between the G protein coupled receptor and a ligand, (6) as a agent for the prevention and/or treatment of various diseases, comprising a compound that alters the binding property between the G protein coupled receptor and a ligand, (7) for quantification of the receptor protein, its partial peptide or salts, (8) for neutralization by antibodies to the receptor protein, its partial peptide or salts and (9) for preparation of a non-human animal bearing the DNA encoding the G protein coupled receptor.
Patent NZ-511684-A (NZ)
Title: Electrical connecting device for contacting conductor strands
Inventor: LADSTATTER GERALD
IPC: F21S4/00
Filed: 1999-12-27
Abstract: An electrical connection device for contacting conductor wires of a plurality of electrical conductors (12), running in a strip-like manner, of a conductor wire combination, with the conductor wires of electrical connection lines of an electrical consuming unit, in particular a light of a lighting strip system.  The connection device (13) has a coupling part (13a) and a counter-coupling element (13b) having contact elements (16) which upon plugging together of the counter-coupling element (13b) with the coupling parts (13a) each make a current connection to associated conductor wires.  The contact elements (16) are arranged in two rows (R1, R2) extending transversely to the conductor wires, and there is associated with one row (R1) a contact position selection device (25a) for displacing at least one contact element (16) between at least two neighbouring contact positions.  For the purpose of improving the adaptability of the connection device to different functions and/or current supplies and/or installation situations, there is also displaceably arranged in the second row (R2) a contact position selection device (25b) for moving at least one of the contact elements (16) arranged in this second row (R2) between two contact positions neighbouring one another.
Patent NZ-511884-A (NZ)
Title: Easy-to-open covers for bottles of sparking wines having cover with a skirt that has two lines of weakness
Inventor: DAUTREPPE BERNARD
IPC: B65D55/06
Filed: 1999-11-24
Abstract: An easy-to-open overcapping cover 1, comprising a head and a skirt and an upper and a lower line of weakness 43, 44. The lower line 44 defines an upper part 10 and a lower part 11 to the cover. The distance between the upper and lower lines of weakness is defined as at least half of the height H between the lower line and top of the cover. The upper part of the cover has a gripping tab 46 with notches to direct the tearing of the cover such that when the tab is pulled for the first time, it removes along with it the whole upper part of the cover.
Patent NZ-516395-A (NZ)
Title: A method for the treatment or prevention of coronary graft vasospasm
Inventor: LEHTONEN LASSE
IPC: A61P9/00
Filed: 2000-06-29
Abstract: The use of (-)-[[1, 4, 5, 6-tetrahydro-4-methyl6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the treatment of or prevention of coronary graft vasospasm.
Patent NZ-516912-A (NZ)
Title: Method of forming a composite panel
Inventor: PIETER ANTHONEY VANDERWERF
IPC: B28B19/00
Filed: 2002-01-30
Abstract: he forming of a composite panel with a façade comprising a planar arrangement of thin facers on a body of structural backing material.  Provision of a substantially flat casting bed, providing a plurality of facers each having a substantial rectangular configuration with a chamfer along each rear-end wall corner and along at least one rear side wall corner, arranging the plurality of individual facers in abutting relationship atop the casting bed and in a selected geometric pattern in a face-down planar configuration so that the chamfers on the facers open rearwardly and cooperatively define narrow elongated channels at joints between contiguous facers. A sealant is deposited in the channels between facers to prevent the structural backing material from penetrating the joints between facers during casting.
Patent NZ-518443-A (NZ)
Title: Energy food product including galactose and optionally including creatine
Inventor: KING RODERICK FREDERICK GERARD
IPC: A23L1/09
Filed: 2000-10-18
Abstract: Disclosed herein is an energy multi-saccharide food product comprising: galactose 5 to 20% creatine 10 to 25% carbohydrate 50 to 75% fat 0 to 10% fibre 0 to 10% and optional further ingredients, wherein the ingredients total 100%; wherein the creatine is composed of granules or powder encapsulated in a dry, water-impervious shell; and wherein the food product is effective for short term replenishment of glycogen reserves.
Patent NZ-520299-A (NZ)
Title: Integrin expression inhibitors containing sulphonamide derivatives
Inventor: WAKABAYASHI TOSHIAKI
IPC: C07D411/12
Filed: 2001-02-01
Abstract: A sulphonamide compound of formula (IA) or a pharmacologically acceptable salt or a hydrate thereof is used in the manufacture of a medicament for inhibiting integrin expression. In formula (IA) the Aa ring is an optionally substituted monocyclic or bicyclic aromatic ring; the Ba ring is an optionally substituted 6-membered cyclic unsaturated hydrocarbon or unsaturated 6-membered heterocycle containing one nitrogen atom as a heteroatom; the Ca ring is an optionally substituted 5-membered heterocycle containing 1 or 2 nitrogen atoms; R1a is hydrogen or alkyl; Wa is a single bond or -CH=CH-; Ya is carbon atom or nitrogen atom; Za is-N(R2a)- or nitrogen atom and R2a is hydrogen or alkyl; provided that the medicament for inhibiting integrin expression does not includes an agent for treating cancer.
Patent NZ-522115-A (NZ)
Title: Selected compounds for the treatment of fibromyalgia and chronic fatigue syndrome
Inventor: ROBERTSON DAVID W
IPC: A61P21/00
Filed: 2001-04-17
Abstract: Use of a compound selected from the group consisting of apomorphine, pergolide, ropinirole, octahydropyrazolo[3,4- g]quinolines, and trans-(+/-)-substituted-5,5a,6,7,8,9-,9a,10-octahydropyrimido[4,5g]quinolines, and their pharmaceutically acceptable salts for the treatment of neuromuscular disorders is disclosed, particularly for the preparation of a medicament for treating, symptoms of fibromyalgia syndrome and chronic fatigue syndrome.
Patent NZ-524748-A (NZ)
Title: Waste processing method
Inventor: BELL STANLEY PETER
IPC: C05F17/00
Filed: 2001-08-31
Abstract: The present invention relates to a method of processing biodegradable waste material comprising the steps of: (i) placing said waste material in a container, (ii) adding soil containing bacteria to said waste material, (iii) applying liquid to said waste material, and (iv) periodically aerating said waste material, whereby to biodegrade said waste material to a soil material.
Patent NZ-525401-A (NZ)
Title: Prodrugs of a 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic
Inventor: HECKER SCOTT J
IPC: A61K31/546
Filed: 2001-03-20
Abstract: Prodrug of 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid having formula (III) or formula (IV) or a pharmaceutically acceptable salt thereof are disclosed, wherein R'2 is an acyl group that is cleaved by an enzyme found in mammals; A, B, L, G, E, and J are each independently nitrogen or carbon, wherein the specific juxtaposition of groups A, B, and L forms a heterocyclic group as shown in the specification; and Q is selected from the group consisting of nitrogen and -CX, wherein X is selected from the group consisting of hydrogen and chlorine. These prodrugs are substantially more water soluble at or near neutral pH than the parent compound.
Patent NZ-526675-A (NZ)
Title: Hydrophobic polyurethane foam as backing material for bandages
Inventor: HADDOCK TERESA
IPC: A61L15/16
Filed: 2003-06-25
Abstract: The use of hydrophobic polyurethane foam as a backing material for bandages and bandages made with hydrophobic polyurethane foam backings are disclosed, wherein the bandage comprises a hydrophobic polyurethane foam backing; and a pad configured as an island pad; wherein the polyurethane foam backing has a thickness of from about 0.1 mm to about 0.7 mm. The bandages are flexible, waterproof, and breathable.
Patent NZ-530098-A (NZ)
Title: Templated molecules and methods for using such molecules
Inventor: PEDERSEN HENRIK
IPC: C12N/
Filed: 2002-06-20
Abstract: A method for synthesising a composition of different templated molecules comprising a plurality of functional groups, said method comprising the steps of: (i) providing a plurality of templates having different coding elements and/or a different order of coding elements, said templates comprising a plurality of nucleotides and a sequence of n coding elements, wherein each coding element comprises at least one recognition group capable of recognising a predetermined complementing element, and wherein n is an integer of more than 1, (ii) providing a plurality of building blocks, wherein each building block comprises (a) at least one complementing element comprising at least one recognition group capable of recognising a predetermined coding element, (b) at least one functional entity comprising at least one functional group and at least one reactive group, and (c) at least one linker separating the at least one functional entity from the at least one complementing element, (iii) contacting each of said coding elements with a complementing element capable of recognising said coding element, said complementing element comprising a plurality of nucleotides, (iv) optionally, obtaining a complementing template, and (v) obtaining a composition of different templated molecules each comprising covalently linked, functional groups by linking, by means of a reaction involving reactive groups, a functional group of at least one functional entity to a functional group of another, functional entity, wherein each templated molecule is linked by means of a linker to the complementing template or template that templated the synthesis of the templated molecule, and wherein the synthesis of the templated molecules does not involve ribosome mediated translation of a nucleic acid.
Patent NZ-532273-A (NZ)
Title: Multi-line gaming machine with single wager option
Inventor: OLIVE SCOTT
IPC: A63F13/00
Filed: 2004-04-13
Abstract: A gaming machine for playing a multi-line spinning reel game includes a controller and a display upon which images of symbols are displayed in accordance with the control by the controller. As usual the player will win a prize if certain reels line up in a single spin. The player is constrained to wager a single amount on each play of the game and may not vary the amount wagered. The single wager amount provides eligibility to all lines of the game and bonus features of the game, and no choice of other wagering options is provided. Under this constraint jackpot weighting for different size bets is not necessary, and the game statistics can be tailored to the one allowed wager rather than to a large range of bet profiles, to permit a more direct appeal to the target player.